Triple

T11074348
Position Surface form Disambiguated ID Type / Status
Subject World Health Organization Model List of Essential Medicines E261826 entity
Predicate isPartOf P10 FINISHED
Object World Health Organization essential medicines program E261826 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: World Health Organization essential medicines program | Statement: [World Health Organization Model List of Essential Medicines, isPartOf, World Health Organization essential medicines program]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: World Health Organization essential medicines program
Context triple: [World Health Organization Model List of Essential Medicines, isPartOf, World Health Organization essential medicines program]
  • A. World Health Organization Model List of Essential Medicines chosen
    The World Health Organization Model List of Essential Medicines is a periodically updated catalog of the most effective, safe, and cost-efficient medicines deemed essential for meeting the priority health needs of populations worldwide.
  • B. Access to Medicines Program
    The Access to Medicines Program is a Public Citizen initiative that advocates for affordable, equitable access to essential medicines worldwide by challenging high drug prices and restrictive pharmaceutical policies.
  • C. World Health Organization Council on the Economics of Health for All
    The World Health Organization Council on the Economics of Health for All is a high-level advisory body that rethinks and promotes economic policies to prioritize health as a global public good and central goal of development.
  • D. WHO Collaborating Centre for Drug Statistics Methodology
    The WHO Collaborating Centre for Drug Statistics Methodology is a specialized World Health Organization center responsible for developing and maintaining international standards for drug classification and consumption statistics, including the ATC/DDD system.
  • E. Doha Declaration on the TRIPS Agreement and Public Health
    The Doha Declaration on the TRIPS Agreement and Public Health is a 2001 WTO ministerial statement affirming that intellectual property rules should not prevent members from protecting public health and ensuring access to affordable medicines.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69d6aa9983c08190b0ef61603b69feac completed April 8, 2026, 7:20 p.m.
NER Named-entity recognition batch_69d7994e32fc8190a6591d9e82b68f75 completed April 9, 2026, 12:19 p.m.
NED1 Entity disambiguation (via context triple) batch_69e3c8cc77988190aad54f56dbd0f8cf completed April 18, 2026, 6:09 p.m.
Created at: April 8, 2026, 9:26 p.m.